Related Experiment Video

Updated: May 20, 2026

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
06:59

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing

Published on: May 12, 2023

FOLFIRINOX in locally advanced pancreatic cancer: the starting point for questioning

Antonin Levy, Cyrus Chargari, Florence Huguet

    Pancreas
    |July 12, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
    06:21

    Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

    Published on: May 10, 2024

    Related Experiment Videos

    Last Updated: May 20, 2026

    Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
    06:59

    Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing

    Published on: May 12, 2023

    Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
    06:21

    Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

    Published on: May 10, 2024

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges.

    The Lancet. Respiratory medicine·2026

    AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.

    Journal for immunotherapy of cancer·2026

    HMGA2::NCOR2 fusion-driven giant cell tumors: Diagnosis and treatment.

    Critical reviews in oncology/hematology·2026

    Dedifferentiated Chondrosarcoma: Current Advances and Future Perspectives.

    Current treatment options in oncology·2026

    RAS signaling at the crossroads of radioresistance and tumor immunity.

    Journal for immunotherapy of cancer·2026

    Redefining Radiotherapy: The Gut as an Active Target in Immuno-oncology.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Care Gaps in Pancreatic Enzyme Replacement Therapy: A Survey of Real-World Practice Patterns in the United States.

    Pancreas·2026

    Association between Serum Human Satellite II RNA and miR-21-5p Levels and Time to Pancreatic Cancer Diagnosis in a Prospective Population-based Study.

    Pancreas·2026

    Early Detection of Pancreatic Adenocarcinoma Using Triple-phase contrast-enhanced Computed Tomography: A Case-control Study.

    Pancreas·2026

    Multi-hole Versus Fully Covered Self-expandable Metal Stents for Distal Biliary Obstruction in Unresectable Pancreatic Cancer.

    Pancreas·2026

    Usefulness of Apparent Diffusion Coefficient Values on Diffusion-Weighted Magnetic Resonance Imaging in Small Pancreatic Neuroendocrine Neoplasms.

    Pancreas·2026

    The Effect of Pancreatic Exocrine Insufficiency and Pancreatic Enzyme Replacement Therapy on Gut Microbiome Composition in Pancreatic Disease: A Prospective Cohort Study.

    Pancreas·2026

    Frontotemporal lobar degeneration therapeutic development pipeline: 2026.

    Alzheimer's & dementia (New York, N. Y.)·2026

    Alveolar soft part sarcoma of the female genital tract: a clinicopathological and molecular genetic study of 26 cases.

    Histopathology·2026

    Plasma Exchange and Daratumumab for Myeloma Cast Nephropathy.

    American journal of hematology·2026

    [A CASE OF MALIGNANCY ARISING IN A NEOBLADDER MORE THAN 50 YEARS AFTER RECONSTRUCTION].

    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·2026

    The p.V27A Variant of L-Asparaginase II Minimizes Glutaminase Activity Without Compromising Anti-Leukemic Function.

    Archives of biochemistry and biophysics·2026

    Risk of metachronous esophageal squamous cell carcinoma after endoscopic submucosal dissection in patients with multiple Lugol-voiding lesions: a long-term study.

    Endoscopy·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us